23.29
price down icon2.92%   -0.70
pre-market  Pre-market:  23.01   -0.28   -1.20%
loading

Celldex Therapeutics Inc Stock (CLDX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
96.22%
0.156
4.131 1.517 0.268 0.967
Operating Expenses
20.78%
40.76
51.46 42.76 33.47 33.44
Benefits Costs and Expenses
5.48%
40.76
38.65 42.76 33.47 33.44
Costs And Expenses
21.24%
40.76
51.76 42.76 33.47 33.44
Operating Income/Loss
14.74%
-40.61
-47.63 -41.24 -33.20 -32.47
Income/Loss From Continuing Operations Before Tax
17.66%
-40.61
-34.51 -41.24 -30.50 -29.36
Income/Loss From Continuing Operations After Tax
353.21%
-32.81
-7.239 -38.26 -30.50 -29.36
Net Income/Loss
24.24%
-32.81
-43.31 -38.26 -30.50 -29.36
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
4,782%
0.0589
0.00121 0.0473 0.0473 0.0472
Diluted Average Shares
4,782%
0.0589
0.00121 0.0473 0.0473 0.0472
Basic Earnings Per Share
33.33%
-0.56
-0.84 -0.81 -0.65 -0.62
Diluted Earnings Per Share
33.33%
-0.56
-0.84 -0.81 -0.65 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):